dosimetry phantoms

CIRS ATOM phantoms are a full line of anthropomorphic, cross sectional dosimetry phantoms designed to investigate organ dose, whole body effective dose as well as verification of delivery of therapeutic radiation doses.

ATOM is the only line of dosimetry phantoms to range in sizes from newborn to adult. Six models are available: newborn, 1-year, 5-year and 10-year old pediatric phantoms as well as adult male and female phantoms.

Each phantom is sectional in design with traditional 25 mm thick sections. The sectional surfaces are extremely flat and smooth and do not require any special coatings or treatment. This results in minimal interfaces between the slabs when viewed in a scout or projection X-ray. The ATOM line also differs from other dosimetry phantoms by providing optimized TLD locations specific to 21 inner organs.

Tissue-equivalent epoxy resins are used in all aspects of the phantom. CIRS technology offers superior tissue simulation Dosimetry Verification Phantoms by covering a wider range of energy levels from diagnostic to therapeutic. In addition, all bones are homogeneous and are formulated to represent age appropriate, average bone composition. CIRS bone formulations offer distinct advantages over natural skeletons and other types of simulated bone. 

  • Phantom models cover a wide range of patient ages
  • Organ specific dosimetry with minimal detectors
  • Superior tissue simulation and lifelike imaging properties
  • Homogeneous bone
  • Accommodates wide variety of detectors
  • Age appropriate references

This product or an optional accessory of this product requires a CIRS dosimetry cavity code before an order can be placed. Please refer to the Dosimetry Cavity Codes document to identify the CIRS code for the probe you intend to use with this product.

For more information: www.cirsinc.com


Related Content

News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
Subscribe Now